- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hyperlipidemia Type 3 in United Kingdom
Total 28386 results
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustJuvenile Diabetes Research Foundation; Wellcome Trust; University of Cambridge; National Institute for Health Research, United KingdomCompletedType 1 DiabetesUnited Kingdom
-
King's College Hospital NHS TrustUnknownType 1 Diabetes MellitusUnited Kingdom
-
Imperial College LondonCompleted
-
University of EdinburghTerminated
-
Imperial College LondonCompletedType 2 DiabetesUnited Kingdom
-
Kastle Therapeutics, LLCIonis Pharmaceuticals, Inc.CompletedMetabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditionsUnited States, Taiwan, Brazil, Canada, South Africa, United Kingdom, Singapore
-
University of PortsmouthPortsmouth Hospitals NHS TrustCompleted
-
Royal Devon and Exeter NHS Foundation TrustNIHR Exeter Clinical Research FacilityCompleted
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
University of DundeeCompleted
-
Liverpool John Moores UniversityRoyal Liverpool University Hospital; University of Birmingham; University of... and other collaboratorsCompleted
-
University of HullCompleted
-
Vico Therapeutics B. V.RecruitingHuntington Disease | Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1Israel, Germany, United Kingdom, Poland, Denmark, Netherlands, France
-
Liverpool Hope UniversitySuspended
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
University of CambridgeMedical University of Graz; University Hospital Birmingham NHS Foundation Trust and other collaboratorsCompletedHypoglycemia | Type 1 Diabetes Mellitus | ArrythmiaUnited Kingdom
-
London North West Healthcare NHS TrustUnknown
-
University of ExeterUniversity of British Columbia; Medical Research CouncilRecruitingType 2 DiabetesUnited Kingdom
-
University of SurreySanofiCompletedType 2 DiabetesUnited Kingdom
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
University Hospitals, LeicesterNational Institute for Health Research, United KingdomCompletedType 2 Diabetes MellitusUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingGrade 1 Meningioma | Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma | Unresectable MeningiomaUnited States
-
Loughborough UniversityNottingham University Hospitals NHS Trust; Nottingham Trent UniversityCompletedObesity | Insulin Resistance | Type2 Diabetes Mellitus | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
University of DundeeCompleted
-
Alizé PharmaUnknownType 2 Diabetes MellitusUnited Kingdom
-
Daniela ElleriCambridge University Hospitals NHS Foundation TrustUnknown
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompleted
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Diabetes UKCompleted
-
University of ReadingRecruiting
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompletedType 2 DiabetesUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknown
-
Glaxo WellcomeCompletedHIV InfectionsUnited States
-
University of ExeterDiabetes UKCompletedType 2 DiabetesUnited Kingdom
-
The Royal Bournemouth HospitalMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited Kingdom
-
University Hospitals, LeicesterWarwick Medical SchoolCompleted
-
Thames Valley UniversityWembley Health Care centre, NHS, UK.; Monks Park Primary care centre, NHS UK.; Willesden Health centre, NHS, UK...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Loughborough UniversityUniversity Hospitals, LeicesterUnknownType 2 Diabetes MellitusUnited Kingdom
-
MedImmune LLCCompletedObesity | Diabetes Mellitus, Type IIUnited Kingdom
-
Tameside Hospital NHS Foundation TrustWithdrawnEndothelial Dysfunction | Bone DiseaseUnited Kingdom
-
Vanderbilt UniversityUniversity of California, IrvineCompletedCondition 1 - Educational Condition (Educational Book Group) | Condition 2 - Non-educational Condition (Non-educational Book Group) | Condition 3 - Control Condition (No-book Group)United States
-
University of AberdeenRecruiting
-
University of CambridgeDiabetes UKCompletedType 1 Diabetes MellitusUnited Kingdom
-
Natasha DukeUniversity of SouthamptonCompletedType 2 DiabetesUnited Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited Kingdom
-
University of California, IrvineWithdrawnAnesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries | Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)United States
-
King's College LondonActive, not recruiting
-
University of CambridgeCompleted
-
National Cancer Institute (NCI)Active, not recruitingAstrocytoma, IDH-Mutant, Grade 2 | Astrocytoma, IDH-Mutant, Grade 3United States